Eliglustat
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for Eliglustat, covering 2015-03-23 to 2026-01-02. Get the full timeline:
Most recent: Clinical Trial Update: GSL Synthetase Inhibitor Eliglustat Combined With CD30 Target Immunotherapy for the Treatment of of CD30+ Lymphoma [Phase 1, Phase 2]